1. Home
  2. KYMR vs NWE Comparison

KYMR vs NWE Comparison

Compare KYMR & NWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • NWE
  • Stock Information
  • Founded
  • KYMR 2015
  • NWE 1923
  • Country
  • KYMR United States
  • NWE United States
  • Employees
  • KYMR N/A
  • NWE N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • NWE Power Generation
  • Sector
  • KYMR Health Care
  • NWE Utilities
  • Exchange
  • KYMR Nasdaq
  • NWE Nasdaq
  • Market Cap
  • KYMR 3.1B
  • NWE 3.5B
  • IPO Year
  • KYMR 2020
  • NWE N/A
  • Fundamental
  • Price
  • KYMR $43.51
  • NWE $57.95
  • Analyst Decision
  • KYMR Strong Buy
  • NWE Buy
  • Analyst Count
  • KYMR 15
  • NWE 7
  • Target Price
  • KYMR $58.53
  • NWE $60.00
  • AVG Volume (30 Days)
  • KYMR 722.6K
  • NWE 489.3K
  • Earning Date
  • KYMR 10-30-2025
  • NWE 10-27-2025
  • Dividend Yield
  • KYMR N/A
  • NWE 4.55%
  • EPS Growth
  • KYMR N/A
  • NWE 7.14
  • EPS
  • KYMR N/A
  • NWE 3.67
  • Revenue
  • KYMR $44,711,000.00
  • NWE $1,527,970,000.00
  • Revenue This Year
  • KYMR $58.45
  • NWE $6.15
  • Revenue Next Year
  • KYMR N/A
  • NWE $4.73
  • P/E Ratio
  • KYMR N/A
  • NWE $15.80
  • Revenue Growth
  • KYMR N/A
  • NWE 3.78
  • 52 Week Low
  • KYMR $19.45
  • NWE $50.43
  • 52 Week High
  • KYMR $53.27
  • NWE $59.89
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 53.28
  • NWE 62.41
  • Support Level
  • KYMR $39.84
  • NWE $56.87
  • Resistance Level
  • KYMR $43.43
  • NWE $58.63
  • Average True Range (ATR)
  • KYMR 2.03
  • NWE 0.97
  • MACD
  • KYMR 0.15
  • NWE -0.09
  • Stochastic Oscillator
  • KYMR 78.76
  • NWE 66.38

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.

Share on Social Networks: